These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 38588863)

  • 1. Prognosis and antithrombotic practice patterns in patients with recurrent and transient atrial fibrillation following acute coronary syndrome: A nationwide study.
    Petersen JK; Butt JH; Yafasova A; Torp-Pedersen C; Sørensen R; Kruuse C; Vinding NE; Gundlund A; Køber L; Fosbøl EL; Østergaard L
    Int J Cardiol; 2024 Jul; 407():132017. PubMed ID: 38588863
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Incidence of ischaemic stroke and mortality in patients with acute coronary syndrome and first-time detected atrial fibrillation: a nationwide study.
    Petersen JK; Butt JH; Yafasova A; Torp-Pedersen C; Sørensen R; Kruuse C; Vinding NE; Gundlund A; Køber L; Fosbøl EL; Østergaard L
    Eur Heart J; 2021 Nov; 42(44):4553-4561. PubMed ID: 34477838
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antithrombotic strategies and outcomes in acute coronary syndrome with atrial fibrillation.
    Chamberlain AM; Gersh BJ; Mills RM; Klaskala W; Alonso A; Weston SA; Roger VL
    Am J Cardiol; 2015 Apr; 115(8):1042-8. PubMed ID: 25726381
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antithrombotic therapy in coronary artery disease patients with atrial fibrillation.
    Wei L; Su E; Liu W; Xing W; Liu X; Zhang Y; Wang S; Cheng Q; Qi D; Gao C
    BMC Cardiovasc Disord; 2020 Jul; 20(1):323. PubMed ID: 32631244
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prestroke and Poststroke Antithrombotic Therapy in Patients With Atrial Fibrillation: Results From a Nationwide Cohort.
    Gundlund A; Xian Y; Peterson ED; Butt JH; Gadsbøll K; Bjerring Olesen J; Køber L; Torp-Pedersen C; Gislason GH; Loldrup Fosbøl E
    JAMA Netw Open; 2018 May; 1(1):e180171. PubMed ID: 30646049
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Anticoagulation status and adherence in patients with atrial fibrillation hospitalized for ACS and the impact on 1-year prognosis: a multicenter cohort study].
    Zhu LY; Li Q; Yu LY; Liu Y; Chen YN; Wang Z; Zhang SY; Li J; Liu Y; Zhao YL; Xi Y; Pi L; Sun YH
    Zhonghua Xin Xue Guan Bing Za Zhi; 2023 Jul; 51(7):731-741. PubMed ID: 37460427
    [No Abstract]   [Full Text] [Related]  

  • 7. Characteristics and antithrombotic treatment patterns of patients with concomitant coronary artery disease and atrial fibrillation from Thailand's COOL-AF registry.
    Winijkul A; Kaewkumdee P; Yindeengam A; Krittayaphong R
    BMC Cardiovasc Disord; 2021 Mar; 21(1):117. PubMed ID: 33653277
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of known or new-onset atrial fibrillation on 2-year cardiovascular event rate in patients with acute coronary syndromes: results from the prospective EPICOR Registry.
    Zeymer U; Annemans L; Danchin N; Pocock S; Newsome S; Van de Werf F; Medina J; Bueno H
    Eur Heart J Acute Cardiovasc Care; 2019 Mar; 8(2):121-129. PubMed ID: 29611427
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association between antithrombotic treatment and outcomes at 1-year follow-up in patients with atrial fibrillation: the EORP-AF General Long-Term Registry.
    Boriani G; Proietti M; Laroche C; Fauchier L; Marin F; Nabauer M; Potpara T; Dan GA; Kalarus Z; Tavazzi L; Maggioni AP; Lip GYH;
    Europace; 2019 Jul; 21(7):1013-1022. PubMed ID: 30904925
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Post-discharge antithrombotic management and clinical outcomes of patients with new-onset or pre-existing atrial fibrillation and acute coronary syndromes undergoing coronary stenting: Follow-up data of the MATADOR-PCI study.
    De Luca L; Di Lenarda A; Rubboli A; Bolognese L; Gonzini L; Fortuni F; Navazio A; Poletti F; Ledda A; Urbinati S; Gabrielli D; Gulizia MM;
    Eur J Intern Med; 2021 Jun; 88():28-34. PubMed ID: 33838988
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Outcomes of newly diagnosed atrial fibrillation in patients with acute coronary syndromes.
    Bor WLW; Azzahhafi J; Maio ND; van der Sangen NMR; Verburg A; Rayhi S; Peper J; Chan Pin Yin DRPP; Ten Berg JM
    EuroIntervention; 2024 Aug; 20(16):996-1007. PubMed ID: 39155759
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical characteristics, management and outcomes of patients with acute coronary syndrome and atrial fibrillation: real-world data from two nationwide registries in Italy.
    Lucà F; Caretta G; Vagnarelli F; Marini M; Iorio A; Di Fusco SA; Pozzi A; Gabrielli D; Colivicchi F; De Luca L; Gulizia MM
    J Cardiovasc Med (Hagerstown); 2020 Feb; 21(2):99-105. PubMed ID: 31923052
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Time trends in antithrombotic management of patients with atrial fibrillation treated with coronary stents: Results from TALENT-AF (The internAtionaL stENT - Atrial Fibrillation study) multicenter registry.
    Potter BJ; Andò G; Cimmino G; Ladeiras-Lopes R; Frikah Z; Chen XY; Virga V; Goncalves-Almeida J; Camm AJ; Fox KAA
    Clin Cardiol; 2018 Apr; 41(4):470-475. PubMed ID: 29663443
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term prognostic outcomes and implication of oral anticoagulants in patients with new-onset atrial fibrillation following st-segment elevation myocardial infarction.
    Madsen JM; Jacobsen MR; Sabbah M; Topal DG; Jabbari R; Glinge C; Køber L; Torp-Pedersen C; Pedersen F; Sørensen R; Holmvang L; Engstrøm T; Lønborg JT
    Am Heart J; 2021 Aug; 238():89-99. PubMed ID: 33957102
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of the CHADS2 score in acute coronary syndromes: risk of subsequent death or stroke in patients with and without atrial fibrillation.
    Poçi D; Hartford M; Karlsson T; Herlitz J; Edvardsson N; Caidahl K
    Chest; 2012 Jun; 141(6):1431-1440. PubMed ID: 22016485
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Incidence, treatment, and outcomes of atrial fibrillation complicating non-ST-segment elevation acute coronary syndromes.
    Lopes RD; White JA; Atar D; Keltai M; Kleiman NS; White HD; Widimsky P; Zeymer U; Giugliano RP; Tricoci P; Braunwald E; Bode C; Ohman EM; Armstrong PW; Newby LK
    Int J Cardiol; 2013 Oct; 168(3):2510-7. PubMed ID: 23578889
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antithrombotic treatment in patients with atrial fibrillation and acute coronary syndromes: results of the European Heart Rhythm Association survey.
    Lane DA; Dagres N; Dan GA; García Seara J; Iliodromitis K; Lenarczyk R; Lip GYH; Mansourati J; Marín F; Scherr D; Potpara TS
    Europace; 2019 Jul; 21(7):1116-1125. PubMed ID: 30874724
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stroke-prevention strategies in North American patients with atrial fibrillation: The GLORIA-AF registry program.
    McIntyre WF; Conen D; Olshansky B; Halperin JL; Hayek E; Huisman MV; Lip GYH; Lu S; Healey JS
    Clin Cardiol; 2018 Jun; 41(6):744-751. PubMed ID: 29546729
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Time-trends and treatment gaps in the antithrombotic management of patients with atrial fibrillation after percutaneous coronary intervention: Insights from the CHUM AF-STENT Registry.
    Boivin-Proulx LA; Deneault-Marchand A; Matteau A; Mansour S; Gobeil F; Camm JA; Fox KAA; Potter BJ
    Clin Cardiol; 2020 Mar; 43(3):216-221. PubMed ID: 31850592
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Burden of Premature Atrial Complexes and Risk of Recurrent Stroke and Death in Patients with Mild to Moderate Ischemic Stroke.
    Sejr MH; May O; Damgaard D; Bruun NH; Nielsen JC
    J Stroke Cerebrovasc Dis; 2020 Feb; 29(2):104490. PubMed ID: 31839547
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.